510(k) K812050
K812050 is an FDA 510(k) premarket notification submitted by Kallestad Laboratories, Inc. for the device "KALLESTAD ANTISERA TO GENTAMICIN". The FDA issued a decision of Substantially Equivalent on August 3, 1981. The device falls under product code DJI (Antiserum, Gentamicin), a Class II device regulated under 21 CFR 862.3450. Kallestad Laboratories, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 3, 1981
- Date Received
- July 21, 1981
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antiserum, Gentamicin
- Device Class
- Class II
- Regulation Number
- 862.3450
- Review Panel
- TX
- Submission Type